Does NCCIH Have a Sea Buckthorn Page?
Short answer: no dedicated monograph exists. The NCCIH maintains detailed pages for high-profile botanical supplements like turmeric, echinacea, ginseng, and St. John's wort, but sea buckthorn — despite its long traditional use and growing research base — hasn't yet received its own NCCIH-curated summary page.
This isn't unusual. The NCCIH prioritizes botanicals based on US public demand, available clinical research volume, and reported adverse events. Sea buckthorn use in the US is still niche compared to mainstream supplements, even though European and Asian clinical research is extensive.
What this means for you: applying the NCCIH's general framework for evaluating supplement safety to the published sea buckthorn evidence gives you essentially the same protective guidance you'd get from a dedicated monograph.
The NCCIH Framework Applied to Sea Buckthorn
The NCCIH publishes six core principles for safely using any dietary supplement. Let's walk through each one as it applies to sea buckthorn.
Tell your healthcare provider
The NCCIH's first and most repeated recommendation: tell every doctor, pharmacist, and specialist you see about all dietary supplements you take. Sea buckthorn is no exception.
Why this matters for sea buckthorn: it has documented mild antiplatelet, antihypertensive, and hypoglycemic activity. Your physician and pharmacist need this information to correctly assess interactions with any prescription you take.
Read the Supplement Facts label carefully
The NCCIH emphasizes that dietary supplements are not pre-approved by the FDA for safety or efficacy before reaching the market. The Supplement Facts label is your most reliable source of product information.
For sea buckthorn: the label should clearly state the part of the plant used (berry, seed, or pulp), the extraction method (cold-pressed or CO2-extracted), the total weight per serving, and any added ingredients. Vague labels like "proprietary blend" without specifics are a red flag.
Look for third-party verification
The NCCIH specifically recommends looking for verification seals from USP (United States Pharmacopeia), NSF International, or ConsumerLab. These are third-party organizations that test supplements for purity, potency, and contaminants.
For sea buckthorn: heavy metal contamination is a real concern with poorly sourced products, particularly from regions with unregulated soil. USDA Organic certification is helpful but doesn't test for contaminants. Look for brands publishing batch test results for lead, arsenic, cadmium, and mercury.
Be skeptical of "cure" claims
The NCCIH explicitly warns against products claiming to "cure," "detox," or "treat" specific diseases. Dietary supplements cannot legally make these claims under FDA rules — and any product that does is signaling either deception or non-compliance.
For sea buckthorn: legitimate brands describe research-supported benefits (supports cardiovascular function, supports skin barrier, etc.) without claiming to cure disease. Marketing copy claiming sea buckthorn "cures" diabetes, eczema, or cancer should immediately disqualify a product from your consideration.
Consider potential drug interactions
The NCCIH maintains that natural does not mean risk-free, particularly when combined with prescription medications. Many botanical supplements interact meaningfully with common drugs.
For sea buckthorn: three medication categories require physician supervision before adding sea buckthorn:
- Anticoagulants and antiplatelets — warfarin, apixaban, rivaroxaban, clopidogrel, aspirin
- Antihypertensives — ACE inhibitors, ARBs, beta-blockers, diuretics
- Antidiabetic medications — insulin, metformin, sulfonylureas, GLP-1 agonists
For full details, see our side effects and interactions guide and our anticoagulant-specific guide.
Be cautious during pregnancy, breastfeeding, and before surgery
The NCCIH consistently recommends extra caution for botanical supplements in three contexts where safety data is often limited.
For sea buckthorn:
- Pregnancy: culinary amounts are likely safe, but therapeutic doses lack rigorous safety data. See our NCCIH-framework pregnancy guide.
- Breastfeeding: same caution — insufficient data to recommend therapeutic dosing.
- Surgery: discontinue at least 14 days before any planned procedure (including dental surgery) due to mild antiplatelet activity.
What the NCCIH-Aligned Evidence Shows
When you apply NCCIH's evidence-evaluation criteria to published sea buckthorn research, three categories emerge.
| Use Area | Evidence Level | NCCIH-Style Verdict |
|---|---|---|
| Topical use for skin barrier | Strong (multiple RCTs) | Reasonably supported; low-risk for most adults |
| Dry-eye support (oral oil) | Strong (Larmo 2010) | Supported; safe at standard dose |
| Cardiovascular markers (oral) | Moderate | Promising; requires physician oversight if on medications |
| Fatigue & energy (juice) | Moderate (2025 RCT) | New evidence; appears safe at standard dose |
| Anti-cancer claims | Preliminary lab/animal | Insufficient human evidence; not a treatment |
| Diabetes treatment | Preliminary | Supportive only; never replaces medication |
This is what the NCCIH calls a "promising but not proven" botanical: strong traditional use, growing peer-reviewed evidence base, no major safety alerts, and a manageable interaction profile.
Natural doesn't mean automatically safe — and "lacks NCCIH monograph" doesn't mean unsafe. It means you apply the same framework you'd use for any supplement.
Reporting Adverse Events
The NCCIH actively encourages consumers to report adverse reactions from supplements to the FDA, which improves federal monitoring and consumer protection. If you experience an unexpected side effect after taking sea buckthorn:
- Stop the supplement immediately.
- Contact your healthcare provider.
- Report the event to the FDA via MedWatch (the FDA's safety information and adverse event reporting program).
Adverse event reports become part of the database the NCCIH and FDA use to update safety guidance. Your report contributes directly to the next generation of safer supplement use for everyone.
Sea Buckthorn vs. NCCIH-Flagged Botanicals
For context, here's how sea buckthorn's NCCIH-evaluable safety profile compares to other popular botanical supplements that do have NCCIH monographs.
| Botanical | Liver risk | Drug interactions | Pregnancy concerns |
|---|---|---|---|
| Sea buckthorn | Minimal | 3 categories (blood thinners, BP, diabetes) | Insufficient data; avoid therapeutic doses |
| St. John's wort | Low | Extensive (50+ medications) | Avoid |
| Kava | Reported cases | CNS depressants | Avoid |
| Comfrey (oral) | Significant (NCCIH warns against) | Multiple | Avoid completely |
| Turmeric (curcumin) | Rare reports | Anticoagulants, diabetes meds | Culinary OK; high-dose unclear |
Sea buckthorn sits in the lower-risk tier — comparable to turmeric — with a manageable interaction profile and no documented organ toxicity at standard doses.
Important: This article applies general NCCIH safety principles to sea buckthorn evidence. It is not an official NCCIH publication. For NCCIH's primary resources, visit nccih.nih.gov directly.
Bottom Line
Sea buckthorn doesn't have an official NCCIH monograph, but the framework the NCCIH publishes for evaluating any botanical supplement gives a clear verdict: sea buckthorn is generally safe at culinary and standard supplement doses, with predictable interaction concerns in three medication categories and the usual caution around pregnancy, breastfeeding, and surgery.
Use it informed. Read labels carefully. Choose products with third-party testing. Tell your healthcare providers. Watch for interactions with prescription medications. Avoid the rare contexts (pregnancy, surgery prep, active bleeding disorders) where caution is warranted. That's the NCCIH-aligned approach — and it applies just as well to sea buckthorn as it does to the botanicals the NCCIH has formally reviewed.